Displaying items by tag: infant formula

Speculation of a possible joint move by Fonterra and a2 Milk to buy Synlait raises a much bigger strategic question, says agribusiness expert Dr Nic Lees.

OPINION: Media reports say global recalls tied to cereulide toxin contamination in milk-based nutrition brands could inflict combined financial losses exceeding $1 billion.

OPINION: As soon as RNZ realised MP Andrew Hoggard's sister worked for Dairy Companies Association of NZ (DCANZ) and was, shock horror, lobbying government on behalf of its members, it wasted no time accusing him of not managing conflicts of interests.

Manufacturers of infant formula are largely supportive of a proposed new domestic labelling standard for their products.

The once-lucrative Chinese infant formula market is shrinking.

Abbot Laboratories NZ Limited is recalling specific brands and batches of infant formula product for special dietary use imported from the United States because of possible Cranobacter and Salmonella contamination.

China's infant formula market upheaval is creating short-term challenges for Southland milk processor Mataura Valley Milk (MVM).

Are China's dairy market dynamics changing? Yes, according to China market expert Jane Li.

Restrictions on marketing infant formula in Australia have been extended for another three years.

Our dairy industry risks being exposed to a ‘ticking time bomb’ of unethical players unlawfully passing off New Zealand-made and packed milk powder products in China as supplements for babies.